Home » Stocks » CLCS

Cell Source, Inc. (CLCS)

Stock Price: $1.16 USD -0.34 (-22.67%)
Updated May 14, 2021 3:58 PM EDT - Market closed
Market Cap 37.89M
Revenue (ttm) n/a
Net Income (ttm) -5.44M
Shares Out 32.66M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $1.16
Previous Close $1.50
Change ($) -0.34
Change (%) -22.67%
Day's Open 1.50
Day's Range 1.16 - 1.50
Day's Volume 2,650
52-Week Range 0.65 - 2.55


There are no news available yet.

About CLCS

Cell Source, Inc., a biotechnology company, develops cell therapy treatments. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, such as treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various canc... [Read more...]

Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements